Summary

Cholesterol Testing Products And Services Market Growth & Trends

The global cholesterol testing products and services market size is expected to reach USD 31.98 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Insufficient physical activity leads to high cholesterol levels and other conditions, such as obesity, diabetes, and cardiovascular diseases. This factor is anticipated to drive the demand for cholesterol testing products and services in near future.

There is an increased need to control high blood cholesterol levels, in addition to other risk factors such as smoking, high blood pressure, and obesity. This has led to high adoption of diagnostic tools and services. According to the Journal of the American Medical Association (JAMA), while the cholesterol levels in the U.S. youth have improved from 1999 to 2016, only 50% of adolescents and children have the ideal cholesterol range and 25% of them are in the clinically high range.

According to the Journal of the American College of Cardiology, in 2018, 31 million of the U.S. adults had high total cholesterol and around one-third of them had high levels of Low-Density Lipoprotein (LDL). Growing number of people being overweight in U.S. is another factor driving the demand for cholesterol testing products and services. Increasing geriatric population is one of the significant factors driving the market growth. This group of population is prone to various cardiovascular diseases such as stroke and heart attack. Thus, increasing cholesterol level is a substantial risk factor for the aging population, which is expected to drive the product demand.

Cholesterol Testing Products And Services Market Report Highlights

• Testing kits led the market and accounted for a share of 45.8% in 2024. Testing kits provide convenience and user-friendliness, enabling individuals to perform tests at home without laboratory visits.

• Total cholesterol tests dominated the market with a revenue share of 38.6% in 2024. Total cholesterol tests offer a thorough evaluation of an individual’s cholesterol levels, including high density lipoprotein (HDL), LDL, and triglycerides.

• The geriatric segment held the largest revenue share of 46.9% in 2024, aided by the rising prevalence of high cholesterol and cardiovascular diseases (CVDs) among older adults.

• Cardiovascular diseases led the market with a revenue share of 35.5% in 2024, supported by the rising incidence of CVDs, a leading cause of global mortality.

• Hospitals and clinics dominated the market, accounting for a share of 39.1% in 2024. These facilities utilize advanced diagnostic technologies and are staffed by trained professionals to ensure accurate and efficient cholesterol testing.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Test
1.2.3. Age Group
1.2.4. Application
1.2.5. Service Provider
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Cholesterol Testing Products And Services Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Cholesterol Testing Products And Services Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Testing Kits
4.4.1. Testing Kits Market, 2018 - 2030 (USD Million)
4.5. Testing Strips
4.5.1. Testing Strips Market, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Cholesterol Testing Products And Services Market: Test Business Analysis
5.1. Test Market Share, 2024 & 2030
5.2. Test Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Test, 2018 to 2030 (USD Million)
5.4. Total Cholesterol Tests
5.4.1. Total Cholesterol Tests Market, 2018 - 2030 (USD Million)
5.5. High Density Lipoprotein (HDL) Cholesterol Tests
5.5.1. High Density Lipoprotein (HDL) Cholesterol Tests Market, 2018 - 2030 (USD Million)
5.6. Low Density Lipoprotein (LDL) Cholesterol Tests
5.6.1. Low Density Lipoprotein (LDL) Cholesterol Tests Market, 2018 - 2030 (USD Million)
5.7. Triglyceride Tests
5.7.1. Triglyceride Tests Market, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Cholesterol Testing Products And Services Market: Age Group Business Analysis
6.1. Age Group Market Share, 2024 & 2030
6.2. Age Group Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
6.4. Geriatric
6.4.1. Geriatric Market, 2018 - 2030 (USD Million)
6.5. Adult
6.5.1. Adult Market, 2018 - 2030 (USD Million)
6.6. Pediatric
6.6.1. Pediatric Market, 2018 - 2030 (USD Million)
Chapter 7. Cholesterol Testing Products And Services Market: Application Business Analysis
7.1. Application Market Share, 2024 & 2030
7.2. Application Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Cardiovascular Diseases
7.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
7.5. Diabetes
7.5.1. Diabetes Market, 2018 - 2030 (USD Million)
7.6. Obesity
7.6.1. Obesity Market, 2018 - 2030 (USD Million)
7.7. Hyperlipidemia
7.7.1. Hyperlipidemia Market, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Cholesterol Testing Products And Services Market: Service Provider Business Analysis
8.1. Service Provider Market Share, 2024 & 2030
8.2. Service Provider Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Service Provider, 2018 to 2030 (USD Million)
8.4. Hospitals and Clinics
8.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
8.5. Diagnostic Laboratories
8.5.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
8.6. Ambulatory Care Centers
8.6.1. Ambulatory Care Centers Market, 2018 - 2030 (USD Million)
8.7. Others
8.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. Cholesterol Testing Products And Services Market: Regional Estimates & Trend Analysis by Product, Test, Age Group, Application, and Service Provider
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
9.4.1. North America Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.4.2. U.S.
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Framework
9.4.2.3. Competitive Insights
9.4.2.4. U.S. Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3. Canada
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Framework
9.4.3.3. Competitive Insights
9.4.3.4. Canada Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4. Mexico
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Framework
9.4.4.3. Competitive Insights
9.4.4.4. Mexico Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5. Europe
9.5.1. Europe Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.5.2. UK
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Framework
9.5.2.3. Competitive Insights
9.5.2.4. UK Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3. Germany
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Framework
9.5.3.3. Competitive Insights
9.5.3.4. Germany Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4. France
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Framework
9.5.4.3. Competitive Insights
9.5.4.4. France Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.5. Italy
9.5.5.1. Key Country Dynamics
9.5.5.2. Regulatory Framework
9.5.5.3. Competitive Insights
9.5.5.4. Italy Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.6. Spain
9.5.6.1. Key Country Dynamics
9.5.6.2. Regulatory Framework
9.5.6.3. Competitive Insights
9.5.6.4. Spain Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.7. Norway
9.5.7.1. Key Country Dynamics
9.5.7.2. Regulatory Framework
9.5.7.3. Competitive Insights
9.5.7.4. Norway Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.8. Denmark
9.5.8.1. Key Country Dynamics
9.5.8.2. Regulatory Framework
9.5.8.3. Competitive Insights
9.5.8.4. Denmark Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.9. Sweden
9.5.9.1. Key Country Dynamics
9.5.9.2. Regulatory Framework
9.5.9.3. Competitive Insights
9.5.9.4. Sweden Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
9.6.1. Asia Pacific Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.6.2. Japan
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Framework
9.6.2.3. Competitive Insights
9.6.2.4. Japan Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3. China
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Framework
9.6.3.3. Competitive Insights
9.6.3.4. China Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.4. India
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Framework
9.6.4.3. Competitive Insights
9.6.4.4. India Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.5. South Korea
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Framework
9.6.5.3. Competitive Insights
9.6.5.4. South Korea Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.6. Australia
9.6.6.1. Key Country Dynamics
9.6.6.2. Regulatory Framework
9.6.6.3. Competitive Insights
9.6.6.4. Australia Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.7. Thailand
9.6.7.1. Key Country Dynamics
9.6.7.2. Regulatory Framework
9.6.7.3. Competitive Insights
9.6.7.4. Thailand Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
9.7.1. Latin America Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.7.2. Brazil
9.7.2.1. Key Country Dynamics
9.7.2.2. Regulatory Framework
9.7.2.3. Competitive Insights
9.7.2.4. Brazil Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7.3. Argentina
9.7.3.1. Key Country Dynamics
9.7.3.2. Regulatory Framework
9.7.3.3. Competitive Insights
9.7.3.4. Argentina Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8. MEA
9.8.1. MEA Cholesterol Testing Products And Services Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
9.8.2. South Africa
9.8.2.1. Key Country Dynamics
9.8.2.2. Regulatory Framework
9.8.2.3. Competitive Insights
9.8.2.4. South Africa Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key Country Dynamics
9.8.3.2. Regulatory Framework
9.8.3.3. Competitive Insights
9.8.3.4. Saudi Arabia Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.4. UAE
9.8.4.1. Key Country Dynamics
9.8.4.2. Regulatory Framework
9.8.4.3. Competitive Insights
9.8.4.4. UAE Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key Country Dynamics
9.8.5.2. Regulatory Framework
9.8.5.3. Competitive Insights
9.8.5.4. Kuwait Cholesterol Testing Products And Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
10.5.1. Quest Diagnostics Incorporated
10.5.1.1. Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. Eurofins Scientific
10.5.2.1. Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. Spectra Laboratories, Inc. (Fresenius Medical Care)
10.5.3.1. Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Novartis AG
10.5.4.1. Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. Cell Biolabs, Inc.
10.5.5.1. Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Randox Laboratories Ltd.
10.5.6.1. Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. SYNLAB AG
10.5.7.1. Overview
10.5.7.2. Financial Performance
10.5.7.3. Product Benchmarking
10.5.7.4. Strategic Initiatives
10.5.8. BioReference Health, LLC
10.5.8.1. Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. Laboratory Corporation of America Holdings
10.5.9.1. Overview
10.5.9.2. Financial Performance
10.5.9.3. Product Benchmarking
10.5.9.4. Strategic Initiatives
10.5.10. Thermo Fisher Scientific Inc.
10.5.10.1. Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
10.5.11. Clinical Reference Laboratory, Inc.
10.5.11.1. Overview
10.5.11.2. Financial Performance
10.5.11.3. Product Benchmarking
10.5.11.4. Strategic Initiatives
10.5.12. Elabscience Bionovation Inc.
10.5.12.1. Overview
10.5.12.2. Financial Performance
10.5.12.3. Product Benchmarking
10.5.12.4. Strategic Initiatives